spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  ddR 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 10 Aug 2026
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
Diagnostics Oncology FDA
 HSMN NewsFeed - 6 Aug 2026
Harbour BioMed Appoints Dr. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2026
Galaxy Therapeutics Achieves CE Mark for SEAL(TM) Embolization System, Enabling Commercial Launch Across Europe and International Markets
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 24 Jul 2026
Roche Receives FDA Clearance for the Cobas(R) BV/CV Assay, Enabling Fast and Highly Accurate Vaginitis Diagnosis
Diagnostics FDA
 HSMN NewsFeed - 16 Jul 2026
Lilly to Acquire AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Jul 2026
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier(R)
Devices Oncology
 HSMN NewsFeed - 8 Jul 2026
Ventris Medical Addresses Unmet Surgical Needs with New Connext Surgical Matrix
Devices Wound Care Product Launch FDA
 HSMN NewsFeed - 2 Jul 2026
Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Jun 2026
Triveni Bio Raises $65 Million Series C Financing to Expand Scope of First-in-Class Bispecific TRIV-573 Clinical Studies and Drive Next-Stage Company Growth
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jun 2026
Celltaxis Names Co-Founder Eileen Heffernan as CEO to Accelerate Growth and Expand Leadership in Lymphatic Disease Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2026
Subtle Medical Receives FDA Clearance for SubtleHD(TM)(CT), Expanding AI-Powered Image Enhancement into CT Imaging
Devices Radiology FDA
 HSMN NewsFeed - 9 Jun 2026
SpinaFX Medical receives FDA Investigational Device Exemption (IDE) for Triojection(R), its Breakthrough, Minimally-Invasive, Image-Guided Lumbar Disc Treatment
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 8 Jun 2026
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2026
Neuronoff Implants First Patient in DOD-Funded Trial of Injectrode(R) for Neurogenic Bladder in Spinal Cord Injury
Devices Urology
 HSMN NewsFeed - 27 May 2026
Subtle Medical Receives FDA Clearance for SubtleHD(TM)(PET), Next-Generation AI-Powered Image Acceleration and Enhancement Software
Devices Radiology FDA
 HSMN NewsFeed - 26 May 2026
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer
Devices Urology Oncology Mergers & Acquisitions
 HSMN NewsFeed - 22 May 2026
AbbVie Announces Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 May 2026
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 19 May 2026
FRACTURE IDE trial of the Boston Scientific SEISMIQ(TM) 4CE Coronary Intravascular Lithotripsy Catheter Meets Primary Safety and Effectiveness Endpoints
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2026
CREATE Medicines Announces $122 Million Series B Financing to Advance In Vivo CAR Pipeline in Autoimmune Disease and Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 May 2026
Bayesian Health Receives First-Ever FDA Clearance for Continuous AI Sepsis Monitoring
Devices Monitoring FDA
 HSMN NewsFeed - 8 May 2026
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 May 2026
Cytora Ltd. Appoints Dr. Thomas Serena, MD, World Renowned Wound Care Expert to Scientific Advisory Board to Lead Patient Treatment Access and Data Collection for CytoraStem(TM) human Oral Mucosa Stem Cell (hOMSC) Therapy
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 4 May 2026
Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio
Devices Distribution
 HSMN NewsFeed - 30 Apr 2026
Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer(TM) Implant
Devices Orthopaedic
 HSMN NewsFeed - 30 Apr 2026
Photon Raises $16M Series A to Give Patients Control Over Their Prescriptions and Bring Transparency to Pharmacy
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2026
BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology
Devices Product Launch
 HSMN NewsFeed - 28 Apr 2026
Medtronic Announces CE Mark for Stealth AXiS(TM) Surgical System
Devices Surgery Regulatory
 HSMN NewsFeed - 27 Apr 2026
Lilly to Acquire Ajax Therapeutics to Advance Outcomes for Patients with Myelofibrosis and Polycythemia Vera
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2026
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Apr 2026
Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH(TM) Neurovascular Catheter
Devices Neurology Interventional FDA
 HSMN NewsFeed - 14 Apr 2026
Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2026
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Apr 2026
First Implant of KingstronBio's ProStyle M(R) Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Apr 2026
Tetrous(R) Announces Completion of First Cases with EnFix ACL(TM) for ACL Reconstruction
Devices Orthopaedic
 HSMN NewsFeed - 6 Apr 2026
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2026
Zeto Announces FDA 510(k) Clearance of Zeto New Wave(TM), Advancing Efficiency in Outpatient EEG
Devices FDA
 HSMN NewsFeed - 31 Mar 2026
Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Mar 2026
Boston Scientific receives FDA clearance for the Asurys(TM) Fluid Management System
Devices Surgery FDA
 HSMN NewsFeed - 26 Mar 2026
Averna Therapeutics Announces Strategic Leadership Expansion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2026
Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Mar 2026
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
Devices Interventional Oncology
 HSMN NewsFeed - 23 Mar 2026
Viatris Advances Innovative Portfolio with Approval of Effexor(R) in Japan for Adults with Generalized Anxiety Disorder (GAD)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Mar 2026
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
Diagnostics Distribution
 HSMN NewsFeed - 11 Mar 2026
ARTHEx Biotech Granted FDA Fast Track Designation for ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Mar 2026
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 5 Mar 2026
Mitria Medical Announces First Use of Novel Mitral Valve Repair Device in U.S. Under Single Patient Expanded Access
Devices Cardiology Interventional
 HSMN NewsFeed - 4 Mar 2026
First-in-Human Use of CereVasc(R) eShunt(R) System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes
Devices Neurosurgery
 HSMN NewsFeed - 25 Feb 2026
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Feb 2026
Synchrony Medical Secures $5M Funding to Fuel Commercial Expansion of its At-Home Airway Clearance Device for Chronic Respiratory Disease
Devices Venture Capital
 HSMN NewsFeed - 17 Feb 2026
Medtronic Announces First Surgery With Hugo(TM) Robotic-Assisted Surgery System In the U.S. Performed at Cleveland Clinic
Devices Surgery
 HSMN NewsFeed - 13 Feb 2026
InVera Medical Achieves European CE Mark Approval for New Vein Infusion Device
Devices Regulatory
 HSMN NewsFeed - 10 Feb 2026
Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 9 Feb 2026
Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Feb 2026
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jan 2026
REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs
Regenerative Medicine FDA
 HSMN NewsFeed - 27 Jan 2026
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
Biopharmaceuticals
 HSMN NewsFeed - 26 Jan 2026
StemCyte Announces FDA Clearance of Expanded Access Program for RegeneCyte(R) (HPC, Cord Blood) to Address Unmet Need in Long COVID
Regenerative Medicine FDA
 HSMN NewsFeed - 22 Jan 2026
Resolve M Therapeutics Exits From Stealth
Biopharmaceuticals
 HSMN NewsFeed - 20 Jan 2026
Think Bioscience Raises $55M in Oversubscribed Series A
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jan 2026
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 15 Jan 2026
BD Receives FDA 510(k) Clearance for EnCor EnCompass(TM) Breast Biopsy and Tissue Removal System
Devices FDA
 HSMN NewsFeed - 15 Jan 2026
Boston Scientific announces agreement to acquire Penumbra, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 14 Jan 2026
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
Devices Neurosurgery Oncology
 HSMN NewsFeed - 12 Jan 2026
Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
Devices Neurology FDA
 HSMN NewsFeed - 9 Jan 2026
Haemonetics Acquires Vivasure Medical Limited
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2026
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jan 2026
BD Marks Milestone with First Phasix(TM) Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
Devices Surgery
 HSMN NewsFeed - 5 Jan 2026
ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 30 Dec 2025
HAI Solutions Receives FDA De Novo Grant for QIKCAP System: Pioneering UVC Technology for Microbial Reduction on Needleless IV Connectors
Devices FDA
 HSMN NewsFeed - 24 Dec 2025
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Dec 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Dec 2025
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
Diagnostics
 HSMN NewsFeed - 17 Dec 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Neurosurgery Oncology
 HSMN NewsFeed - 12 Dec 2025
Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 11 Dec 2025
Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 Dec 2025
EyeYon Medical Ltd. Receives FDA IDE Approval to Initiate U.S. Clinical Study of EndoArt(R), the First Artificial Endothelial Layer for Corneal Edema
Devices Ophthalmology FDA
 HSMN NewsFeed - 4 Dec 2025
SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 3 Dec 2025
Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
Devices Orthopaedic
 HSMN NewsFeed - 28 Nov 2025
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2025
Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board
Devices Cardiology Personnel
 HSMN NewsFeed - 17 Nov 2025
BD Onclarity(TM) HPV Assay for BD COR(TM) and BD Viper(TM) LT Systems Receive WHO Prequalification
Diagnostics Regulatory
 HSMN NewsFeed - 12 Nov 2025
BD Expands PureWick(TM) Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go
Devices Urology Product Launch
 HSMN NewsFeed - 12 Nov 2025
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
Devices Neurology Venture Capital
 HSMN NewsFeed - 10 Nov 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 6 Nov 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Neurosurgery Oncology
 HSMN NewsFeed - 3 Nov 2025
Alcresta Therapeutics Announces FDA Clearance for Expanded Use of RELiZORB(R) (iMMOBILIZED LIPASE) Cartridge for Neonates and Infants
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2025
Brenig Therapeutics Names Megan McGill as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Oct 2025
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Devices Orthopaedic FDA
 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Oct 2025
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2025
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Oct 2025
BD Reaches Major Milestone for Rotarex(TM) Catheter System with First Patient Enrolled in XTRACT(TM) Registry to Advance Real-World Evidence in Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2025
Cardinal Health Launches a New All-In-One Solution for Deep Vein Thrombosis and Pulmonary Embolism Prevention
Devices Product Launch
 HSMN NewsFeed - 6 Oct 2025
Alcresta Therapeutics Expands Executive Leadership to Drive Strategic Initiatives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2025
Natus Acquires Holberg EEG, Expanding Innovation in Neurodiagnostic AI Solutions
Devices Diagnostics Neurology Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2025
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
Devices Oncology Product Launch
 HSMN NewsFeed - 22 Sep 2025
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2025
Amber Implants Secures FDA 510(k) Clearance for VCFix(R) Spinal System: A Next-Generation Solution for Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 15 Sep 2025
Resurfacing Just Changed Forever: Sciton Unveils HALO(R) TRIBRID(TM), the World's First Triple-Wavelength Resurfacing Laser
Devices Dermatology Product Launch
 HSMN NewsFeed - 5 Sep 2025
Roche Receives CE IVDR Approval for HER2 (4B5) Companion Diagnostic Test to Identify HER2-ultralow Breast Cancer and Biliary Tract Cancer Patients
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 2 Sep 2025
Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 28 Aug 2025
Proton Center in South Korea Selects RayStation and RayCare
Devices Oncology
 HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Aug 2025
ProVerum Secures $80 Million Series B Financing to Advance New Treatment for BPH
Devices Urology Venture Capital
 HSMN NewsFeed - 22 Aug 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2025
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Devices FDA
 HSMN NewsFeed - 15 Aug 2025
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Aug 2025
Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity
Biopharmaceuticals
 HSMN NewsFeed - 13 Aug 2025
BTL Expands EMFACE(R) Indications with New FDA Clearance for TMJ Dysfunction
Devices FDA
 HSMN NewsFeed - 11 Aug 2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Aug 2025
ulrich medical USA(R) Announces Full Market Launch of Cortium(R) Universal OCT Spinal Fixation System
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 6 Aug 2025
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2025
Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale
Devices Cardiology Venture Capital
 HSMN NewsFeed - 30 Jul 2025
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
Diagnostics FDA
 HSMN NewsFeed - 29 Jul 2025
Leo Cancer Care Receives FDA 510(k) Clearance for Marie(R) - A Revolutionary Upright Radiotherapy Platform
Devices Oncology FDA
 HSMN NewsFeed - 28 Jul 2025
MapLight Therapeutics Announces $372.5 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Jul 2025
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
Devices Interventional Product Launch
 HSMN NewsFeed - 24 Jul 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Oncology Neurosurgery
 HSMN NewsFeed - 23 Jul 2025
Neuros Medical Announces First Commercial Implant of the Altius(R) Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain
Devices Neurology FDA
 HSMN NewsFeed - 23 Jul 2025
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas(TM) Wearable Injector Technology for Biologic Drugs
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Jul 2025
SPRITAM(R) (levetiracetam) Tablets for Oral Suspension Approved by FDA for Nasogastric and Gastrostomy Tube Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Jul 2025
Centinel Spine(R) prodisc(R) Total Disc Replacement Grows 47% Worldwide in Second Quarter 2025, Setting New Revenue Record
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 18 Jul 2025
B. Braun Expands Heparin Sodium Injection Portfolio to Seven Heparin Premixed Sodium Injection Products
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 17 Jul 2025
Xeltis Announces Positive Data for Xabg, its Coronary Artery Bypass Conduit, in EU Clinical Trial
Devices Surgery Cardiology
 HSMN NewsFeed - 15 Jul 2025
GT Medical Technologies Completes Final Close of Company's Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
Devices Neurosurgery Oncology Venture Capital
 HSMN NewsFeed - 15 Jul 2025
Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2025
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 10 Jul 2025
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Jul 2025
Neuros Medical Secures $56M Series D to Commercialize the Altius(R) System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Devices Venture Capital
 HSMN NewsFeed - 8 Jul 2025
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jul 2025
Boston Scientific Receives FDA Approval for Expanded Labeling of FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Jul 2025
Novartis Provides Update on Phase III GCAptAIN Study of Cosentyx(R) in Giant Cell Arteritis (GCA)
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2025
Q'Apel Medical Appoints Stewart Strong as President and Chief Executive Officer
Devices Neurology Interventional Personnel
 HSMN NewsFeed - 24 Jun 2025
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 23 Jun 2025
Sephience(TM) (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Jun 2025
Johnson & Johnson Launches VOLT(TM) Wrist and Proximal Humerus Plating Systems in the U.S.
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 11 Jun 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 10 Jun 2025
Cristcot Appoints Richard Kim as Chief Commercial Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 4 Jun 2025
Cardinal Health Launches New Medical Device for the Continuous Monitoring of Three Essential Vital Signs in One System
Devices Monitoring Product Launch
 HSMN NewsFeed - 2 Jun 2025
Sanofi to Acquire Blueprint Medicines, Expanding Portfolio in Rare Immunological Disease and Adding Early-stage Pipeline in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2025
Diakonos Oncology Closes $20 Million Financing to Accelerate Phase 2 Glioblastoma Clinical Development Program and Expand Use of Innovative Dendritic Cell Platform for Studies in Other Indications
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 May 2025
BD to Initiate Real-World Patient Data Registry for the Rotarex(TM) Atherectomy System in Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 May 2025
Medtronic Announces Intent to Separate Diabetes Business
Devices Endocrinology Drug Delivery
 HSMN NewsFeed - 20 May 2025
Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 May 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2025
Neutron Therapeutics and Helsinki University Hospital Treat First Head and Neck Cancer Patients Using Accelerator-Based Boron Neutron Capture Therapy
Devices Oncology
 HSMN NewsFeed - 15 May 2025
Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy
Devices Oncology Venture Capital
 HSMN NewsFeed - 14 May 2025
GT Medical Technologies Welcomes New GammaTile(R) Center of Excellence Program Designation
Devices Neurosurgery Oncology
 HSMN NewsFeed - 13 May 2025
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2025
Sumitomo Corporation Acquires Full Ownership of U.S.-based ActivStyle, Provider of Home Medical Supplies for Patients with Chronic Conditions
Devices Mergers & Acquisitions
 HSMN NewsFeed - 7 May 2025
PAQ Therapeutics Appoints Andrew Krivoshik, MD, PhD, as Chief Medical Officer, Announces Addition of Eric Rubin, MD, and Piro Lito MD, PhD, to Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 May 2025
PAQ Therapeutics Announces $39 Million Series B Financing and Initiates Phase 1 Trial to Advance Novel Approach Addressing KRAS-Driven Cancers with High Unmet Need
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 May 2025
Altesa BioSciences announces Katharine Knobil, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2025
Lutris Pharma Announces the Appointment of Seasoned Life Science Executive, Sumant Ramachandra, M.D., Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2025
Boston Scientific Chief Financial Officer (CFO) Dan Brennan to Retire; Jon Monson, Senior Vice President, Investor Relations to Succeed Brennan
Devices Personnel
 HSMN NewsFeed - 21 Apr 2025
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
Devices Monitoring Product Launch
 HSMN NewsFeed - 16 Apr 2025
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Devices Orthopaedic Wound Care Venture Capital
 HSMN NewsFeed - 14 Apr 2025
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America
Devices Personnel
 HSMN NewsFeed - 14 Apr 2025
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 8 Apr 2025
Brainomix Advances Stroke Care with Landmark FDA Clearance
Devices Neurology FDA
 HSMN NewsFeed - 7 Apr 2025
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo(TM) and Plum Duo(TM) Precision IV Pumps
Devices Drug Delivery FDA
 HSMN NewsFeed - 4 Apr 2025
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Apr 2025
Study Links Bacterial Load to Pain in Venous Ulcers, Demonstrating Effective Reduction with MolecuLight
Devices Wound Care
 HSMN NewsFeed - 2 Apr 2025
Append Medical Appoints Shlomi Nachman as Chairman of the Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 21 Mar 2025
Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
Devices Monitoring Personnel
 HSMN NewsFeed - 20 Mar 2025
Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2025
Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Mar 2025
OsteoCentric Technologies Enters into a Non-Exclusive Licensing Agreement with Globus Medical
Devices Orthopaedic Licensing
 HSMN NewsFeed - 10 Mar 2025
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 7 Mar 2025
Zimmer Biomet Receives FDA Clearance for Persona(R) Revision SoluTion(TM) Femur
Devices Orthopaedic FDA
 HSMN NewsFeed - 5 Mar 2025
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 3 Mar 2025
Boston Scientific Announces Agreement to Acquire SoniVie Ltd.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 19 Feb 2025
Biosion, Inc. Appoints Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2025
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2025
Roche Elecsys sFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Raliable Way to Predict the Risk of Developing Severe Preeclampsia
Diagnostics FDA
 HSMN NewsFeed - 12 Feb 2025
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Feb 2025
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 6 Feb 2025
Accuryn Medical Welcomes Business Innovation Leader to Support Team in Transforming Kidney Care
Devices Monitoring Personnel
 HSMN NewsFeed - 4 Feb 2025
MedRhythms Hires Joel Behnke as Chief Commercial Officer; Announces New Publications in Support of InTandem(R)
Devices Neurology Personnel
 HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jan 2025
Aspen Medical Products Acquires Advanced Orthopaedics
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 28 Jan 2025
AI Optics Receives FDA Clearance, Increasing Patient Access to Retinal Screening
Devices Ophthalmology FDA
 HSMN NewsFeed - 22 Jan 2025
Shotel(TM) Medical Expansion Signals Growing Demand for Its Ankle Arthrodesis Device
Devices Orthopaedic Distribution
 HSMN NewsFeed - 17 Jan 2025
FDA Approves LUMAKRAS(R) (Sotorasib) in Combination with Vectibix(R) (Panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Jan 2025
New Drug Application Initiated with U.S. FDA for TAR-200, the First and Only Intravesical Drug Releasing System for Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 13 Jan 2025
Medtronic Achieves CE Mark Approval for BrainSense Adaptive Deep Brain Stimulation and Electrode Identifier, a Groundbreaking Advance In Personalized, Sensing-Enabled Care for People with Parkinson's Through Innovative Brain-Computer Interface Technology
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 9 Jan 2025
RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2025
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment
Devices Interventional
 HSMN NewsFeed - 3 Jan 2025
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot
Devices Dermatology
 HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 19 Dec 2024
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 17 Dec 2024
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
Diagnostics Product Launch
 HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Devices Cardiology FDA
 HSMN NewsFeed - 6 Dec 2024
EQT Life Sciences Leads Series A Funding Round for Maternal Health Company Nua Surgical
Devices Surgery Venture Capital
 HSMN NewsFeed - 5 Dec 2024
Sapience Therapeutics Strengthens Board of Directors and Management Team with Esteemed Business Development Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Nov 2024
LifeSignals Receives FDA 510(k) Approval for UbiqVue(TM) 2A Multiparameter System
Devices Monitoring FDA
 HSMN NewsFeed - 22 Nov 2024
Bioretec Signed a New Sales and Distribution Agreement to Accelerate the Commercialization of RemeOs(TM) Trauma Screw in the U.S. Civilian Hospital Market
Devices Orthopaedic Distribution
 HSMN NewsFeed - 20 Nov 2024
Medtronic Receives FDA Clearance for New InPen(TM) App, Paving the Way for its Smart MDI System Launch with Simplera(TM) CGM
Devices Monitoring FDA
 HSMN NewsFeed - 18 Nov 2024
Zimmer Biomet Announces CE Mark Certification for Persona(R) Revision Knee System
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 15 Nov 2024
Boston Scientific Closes Acquisition of Axonics, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2024
Stryker Launches Next Generation of SurgiCount+ to Help Improve the Standard of Care in Hospitals for Sponge Management and Blood Loss Assessment
Devices Surgery Product Launch
 HSMN NewsFeed - 13 Nov 2024
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 5 Nov 2024
Xeltis expands leadership team with appointment of Luc Verhees as Vice President of Clinical Business Development
Devices Personnel
 HSMN NewsFeed - 4 Nov 2024
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 1 Nov 2024
CARsgen(R) U.S. Clinical Holds Lifted by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Oct 2024
Evommune Announces $115 Million Series C Financing to Accelerate Advancement of Clinical-Stage Pipeline Addressing Chronic Inflammatory Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Oct 2024
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO(R) in South Korea
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 28 Oct 2024
Zimmer Biomet to Debut New Z1(TM) Femoral Hip System and Clinical Data on G7(R) Acetabular System at 2024 AAHKS Annual Meeting
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 24 Oct 2024
Accent Therapeutics Announces FDA Clearance of IND Application for ATX-559, a First-In-Class Oral DHX9 Inhibitor
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Oct 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Oct 2024
AvenCell Raises $112 Million in Series B; Funding Led by Novo Holdings
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Oct 2024
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
Devices Dermatology FDA
 HSMN NewsFeed - 11 Oct 2024
X-Bolt Announces First U.S. Implant of Pro-X1(R) Trochanteric Nailing System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 10 Oct 2024
Rivermark Medical Closes $30 Million Series C Financing to Advance Development of Flostent(TM) System for Benign Prostatic Hyperplasia
Devices Urology Venture Capital
 HSMN NewsFeed - 10 Oct 2024
Johnson & Johnson MedTech Launches VOLT(TM) Plating System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 9 Oct 2024
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine
Devices Neurology Venture Capital
 HSMN NewsFeed - 8 Oct 2024
BTL's Emsculpt Neo Secures FDA Clearance for Treating Medical Diseases and Conditions, Expanding Market Reach
Devices FDA
 HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Sep 2024
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Sep 2024
B. Braun Medical Receives FDA Clearance for Introcan Safety(R) 2 Deep Access IV Catheter
Devices FDA
 HSMN NewsFeed - 19 Sep 2024
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2024
Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY(TM)+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area
Devices Cardiology FDA
 HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 5 Sep 2024
Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Aug 2024
Neuros Medical Receives FDA Approval for the Altius(R) Direct Electrical Nerve Stimulation System
Devices FDA
 HSMN NewsFeed - 22 Aug 2024
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
Devices Distribution
 HSMN NewsFeed - 20 Aug 2024
Pathalys Pharma Secures $105 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 15 Aug 2024
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 12 Aug 2024
BD Names Michael Feld as President of Life Sciences Segment
Diagnostics Personnel
 HSMN NewsFeed - 9 Aug 2024
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 30 Jul 2024
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
Devices Ophthalmology Regulatory Distribution
 HSMN NewsFeed - 26 Jul 2024
ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Jul 2024
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
Diagnostics Oncology
 HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 15 Jul 2024
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2024
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2024
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
Devices Diagnostics Product Launch
 HSMN NewsFeed - 3 Jul 2024
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 24 Jun 2024
Harmony Biosciences Receives U.S. Food And Drug Administration Approval For Wakix(R) (Pitolisant) In Pediatric Patients With Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Jun 2024
Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXess(TM), its restorative vascular access conduit
Devices FDA
 HSMN NewsFeed - 11 Jun 2024
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI(R) Miniature Handheld Robotic System for Total Knee Arthroplasty
Devices Surgery Distribution
 HSMN NewsFeed - 7 Jun 2024
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS(TM) Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
Devices Orthopaedic FDA
 HSMN NewsFeed - 3 Jun 2024
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
Devices Monitoring Acquisitions
 HSMN NewsFeed - 31 May 2024
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 30 May 2024
McDavid Launches NRG Knee Brace Line with Joint Assistance Hinge System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 28 May 2024
IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 May 2024
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2024
Shoulder Innovations Launches InSet(TM) 95 Humeral Stem
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 16 May 2024
FX Shoulder Solutions, Inc. Receives FDA 510k Clearance for Full-Wedge Augmented Glenoid Baseplates
Devices Orthopaedic FDA
 HSMN NewsFeed - 15 May 2024
Compugen Appoints David Silberman as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 May 2024
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
Devices Orthopaedic FDA
 HSMN NewsFeed - 8 May 2024
Alcyone Therapeutics Announces Appointment of Dr. Norbert Riedel as Chairman of the Board and Dr. Kathrin Meyer as Chief Scientific Officer and Head of Research & Development
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 3 May 2024
Leading Academic Neurosurgeons Describe New NICO Myriad SPECTRA(TM) System as a 'Game-Changing Advancement' in Surgical Removal of High-Grade Glioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 30 Apr 2024
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2024
Repertoire(R) Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2024
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS(TM) System
Devices FDA
 HSMN NewsFeed - 19 Apr 2024
Legacy Medical Consultants Announces Reeva FT(TM), a Full-Thickness Allograft for Wound Covering and Protection During Treatment
Devices Wound Care Product Launch Reimbursement
 HSMN NewsFeed - 8 Apr 2024
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS(R) (edaravone)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Apr 2024
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Apr 2024
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2024
NEOS Cranial LOOP(TM) Receives FDA Clearance for CustomizedBone(TM) Use
Devices Neurosurgery FDA
 HSMN NewsFeed - 1 Apr 2024
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Mar 2024
RIVANNA(R) Appoints Craig Loomis as Senior Director of Product Management
Devices Radiology Personnel
 HSMN NewsFeed - 28 Mar 2024
Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Mar 2024
Astellas Receives Positive CHMP Opinion for XTANDI(TM) in Additional Recurrent Early Prostate Cancer Treatment Setting
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 14 Mar 2024
Celluma Light Therapy Introduces the RESTORE Hair Therapy System
Biopharmaceuticals Devices Product Launch
 HSMN NewsFeed - 13 Mar 2024
Ventris Medical Receives 510(k) Additional Clearance for Amplify(R) Standalone Bone Graft Putty
Devices FDA
 HSMN NewsFeed - 12 Mar 2024
Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner(R) Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Mar 2024
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA(R) (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2024
ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices(TM) Cardiopulmonary Management (CPM) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 5 Mar 2024
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2024
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(R) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 27 Feb 2024
Dave Hickey Announces Intent to Retire from BD
Diagnostics Personnel
 HSMN NewsFeed - 27 Feb 2024
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Feb 2024
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 22 Feb 2024
NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
Devices Cardiology Personnel
 HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2024
Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Feb 2024
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 14 Feb 2024
Efemoral Medical Granted Breakthrough Device Designation
Devices Interventional FDA
 HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 7 Feb 2024
Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
Devices Interventional
 HSMN NewsFeed - 6 Feb 2024
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
Devices Wound Care FDA
 HSMN NewsFeed - 30 Jan 2024
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
Diagnostics Oncology
 HSMN NewsFeed - 19 Jan 2024
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Jan 2024
Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
Diagnostics Neurology FDA
 HSMN NewsFeed - 9 Jan 2024
TORL BioTherapeutics Announces Appointment of Mark J. Alles as Chairman and Chief Executive Officer; Highlights Significant Progress of its Oncology Clinical Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Jan 2024
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Jan 2024
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
Devices Regulatory FDA Reimbursement
 HSMN NewsFeed - 28 Dec 2023
HR Pharmaceuticals, Inc. receives exclusive commercialization rights to Poiesis Medical's Dual Balloon Catheter technology in North America
Devices Licensing
 HSMN NewsFeed - 20 Dec 2023
FeelTect secures €1.5 million investment for connected wound treatment technology
Devices Wound Care Monitoring Venture Capital
 HSMN NewsFeed - 13 Dec 2023
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2023
cTRL Therapeutics Appoints Ruben Rodriguez, Ph.D., as Head of Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Dec 2023
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
Devices Diagnostics FDA
 HSMN NewsFeed - 4 Dec 2023
Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2023
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
Devices Product Launch
 HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Nov 2023
RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva(R) Allograft Dermis in Breast Reconstruction
Devices Surgery FDA
 HSMN NewsFeed - 24 Nov 2023
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune(R) Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 22 Nov 2023
Vaccine Partner Valneva receives FDA approval for the World's first chikungunya vaccine using Albumedix' Recombumin(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Nov 2023
BD Names Dr. Ronald Silverman as Chief Medical Officer
Devices Diagnostics Personnel
 HSMN NewsFeed - 20 Nov 2023
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Nov 2023
Vejle Hospital becomes first center in the world to use RayStation for an online adaptive treatment with augmented CBCT
Devices Oncology
 HSMN NewsFeed - 10 Nov 2023
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Nov 2023
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
Devices Surgery FDA
 HSMN NewsFeed - 6 Nov 2023
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2023
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next-Generation Needle-Free Blood Draw Technology
Devices FDA Product Launch
 HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Oct 2023
Centinel Spine(R) PMA Application for First-of-its-Kind 2-Level prodisc(R) C Vivo and prodisc C SK Match-the-Disc(TM) Cervical Total Disc Replacement System Filed and Proceeding with Substantive Review
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 12 Oct 2023
Centinel Spine Surgical Stadium Event at NASS 2023 to Demonstrate Value of prodisc(R) Match-the-Disc(TM) Cervical and Lumbar Total Disc Replacement Systems
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 Oct 2023
Body Vision Medical Announces Successful Validation of LungVision(TM) System with Ziehm Imaging's Mobile C-Arms
Devices Radiology
 HSMN NewsFeed - 6 Oct 2023
Amgen Completes Acquisition of Horizon Therapeutics plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2023
2,500 Procedures Completed in U.S. with Centinel Spine's prodisc(R) C Vivo and prodisc C SK Cervical Total Disc Replacement System, Less than One Year After Limited Launch
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 26 Sep 2023
Abyrx Receives FDA Clearance for MONTAGE(R) Settable Bone Putty for Use in Cardiothoracic Surgery
Devices Surgery FDA
 HSMN NewsFeed - 20 Sep 2023
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
Devices FDA
 HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2023
Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 14 Sep 2023
Galderma Launches Advanced New Serum with Alastin Skincare(R) - C-Radical Defense Antioxidant Serum
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 8 Sep 2023
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Sep 2023
Sharps Terminator Launches Innovative Device to Reduce Sharps Medical Plastic Waste by 93%
Devices Product Launch
 HSMN NewsFeed - 7 Sep 2023
Silony Medical acquires Centinel Spine's Global Fusion Business
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2023
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Aug 2023
Haemonetics Announces European Expansion for VASCADE(R) Vascular Closure System
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Aug 2023
Stimlabs(R) LLC Announces Launch of Relese(R) - A Uniquely Fenestrated Allograft for Chronic and Acute Wounds
Devices Regenerative Medicine Wound Care Product Launch
 HSMN NewsFeed - 17 Aug 2023
AbbVie Announces European Commission Approval of AQUIPTA(R) (atogepant) for the Preventive Treatment of Migraine in Adults
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 7 Aug 2023
Kytopen Names Michael Chiu, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2023
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
Devices Cardiology FDA
 HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Aug 2023
Body Vision Medical Forges Exclusive Distribution Agreements to Extend Global Access to LungVision(TM) AI Imaging System
Devices Radiology Surgery Distribution
 HSMN NewsFeed - 1 Aug 2023
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
Diagnostics FDA
 HSMN NewsFeed - 24 Jul 2023
Heron Therapeutics Announces Cost Reduction Plan and Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 24 Jul 2023
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
Devices FDA
 HSMN NewsFeed - 21 Jul 2023
Hubly Surgical Raises $3 Million in Oversubscribed Funding Round Following FDA Clearance
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 20 Jul 2023
MediView Receives FDA 510(k) Clearance for XR90 Augmented Reality-Based Visualization and Navigation Platform
Devices Surgery FDA
 HSMN NewsFeed - 18 Jul 2023
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Biopharmaceuticals
 HSMN NewsFeed - 17 Jul 2023
Getinge recieves US FDA 510(k) clearance for Servo-air(R) Lite
Devices FDA
 HSMN NewsFeed - 17 Jul 2023
ViewRay(R) Files Voluntary Chapter 11 Petitions
Devices Oncology
 HSMN NewsFeed - 11 Jul 2023
GI Dynamics Announces Company Rebrand as Morphic Medical(R) Reintroducing Flagship Product as RESET(R)
Devices Endocrinology
 HSMN NewsFeed - 3 Jul 2023
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 26 Jun 2023
Genesys Spine Launches SIros O(TM) Transfixing SI Joint Fusion System
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 22 Jun 2023
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Jun 2023
Aethlon Medical Announces Investigation of the Hemopurifier(R) for Use in Organ Transplantation
Devices
 HSMN NewsFeed - 13 Jun 2023
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology
 HSMN NewsFeed - 12 Jun 2023
FDA Clears CorNeat EverPatch, World's First Non-degradable, Synthetic Tissue Substitute for Ophthalmic Surgery
Devices Ophthalmology FDA
 HSMN NewsFeed - 9 Jun 2023
Astellas Submits New Drug Application for Zolbetuximab in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Jun 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 7 Jun 2023
Innova Vascular Earns FDA Clearance for Two New Thrombectomy Devices: Laguna Clot Retriever(TM) System and Malibu Aspiration Catheter(TM) System
Devices Interventional FDA
 HSMN NewsFeed - 6 Jun 2023
Artelon, Inc.'s FlexBand(R), FlexPatch(R), and FlexBand Plus(R) earn FDA Clearance for Ligament Reinforcement
Devices Orthopaedic Surgery FDA
 HSMN NewsFeed - 6 Jun 2023
Acepodia Secures $100 Million Series D Financing to Advance
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Jun 2023
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Devices Interventional Product Launch FDA
 HSMN NewsFeed - 25 May 2023
Medtronic to acquire wearable insulin patch maker EOFlow
Devices Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 24 May 2023
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 24 May 2023
RayCare is interoperable with Varian TrueBeam
Devices Oncology
 HSMN NewsFeed - 16 May 2023
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
Diagnostics FDA
 HSMN NewsFeed - 15 May 2023
Potrero Medical Announces Maclean Health as Government Sector Distributor of Record
Devices Monitoring Distribution
 HSMN NewsFeed - 2 May 2023
Conventus Flower Orthopedics Appoints Anjan R. Shah, MD as Chief Medical Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 27 Apr 2023
Eitan Medical launches connected Avoset(TM) Infusion Platform
Devices Product Launch
 HSMN NewsFeed - 26 Apr 2023
Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Apr 2023
Strata Oncology Announces Launch and Medicare Coverage for Strata Select, a First-of-its-kind Immunotherapy Test
Diagnostics Oncology Product Launch Reimbursement
 HSMN NewsFeed - 21 Apr 2023
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA(R)) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Apr 2023
Cardinal Health launches Stray Away(TM) Hair Management Drape in collaboration with MedStar Health's Institute for Innovation
Devices Surgery Product Launch
 HSMN NewsFeed - 13 Apr 2023
BioVentrix(R) Closes $48.5 Million Series A Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 11 Apr 2023
Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2023
Reach Neuro Receives FDA Breakthrough Device Designation for Device to Restore Arm and Hand Movement to Chronic Stroke Patients
Devices Neurology FDA
 HSMN NewsFeed - 6 Apr 2023
Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT(R)
Devices Cardiology FDA
 HSMN NewsFeed - 5 Apr 2023
Abyrx Receives Additional FDA Clearances for MONTAGE(R) Settable, Resorbable Bone Putty as Bone Void Filler and Cranial Bone Cement
Devices FDA
 HSMN NewsFeed - 30 Mar 2023
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
Devices Orthopaedic FDA
 HSMN NewsFeed - 29 Mar 2023
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 15 Mar 2023
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Mar 2023
QurAlis Closes $88 Million Series B Financing to Advance Precision Medicines for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 2 Mar 2023
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian(R) MRI-Guided Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 1 Mar 2023
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Feb 2023
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Devices Cardiology Regulatory
 HSMN NewsFeed - 16 Feb 2023
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 15 Feb 2023
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
Diagnostics
 HSMN NewsFeed - 8 Feb 2023
Ostial Corp Closes $7.5M Series C Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 3 Feb 2023
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Feb 2023
Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 30 Jan 2023
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 25 Jan 2023
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Jan 2023
FDA Agrees to Expanded Access Program for the BioVentrix(R) Revivent TC(R) System for the Treatment of Ischemic Heart Failure
Devices Cardiology FDA
 HSMN NewsFeed - 23 Jan 2023
Cadrenal Therapeutics (Nasdaq: CVKD) Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients with End-Stage Renal Disease and Atrial Fibrillation
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jan 2023
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jan 2023
Conventus Flower Orthopedics Announces Expansion of its Flex-Thread(TM) Technology Platform with FDA Clearance of the Ulna Intramedullary Nail System
Devices Orthopaedic FDA
 HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2023
Arthrex Receives FDA Clearance for TightRope(R) Implant as First, Only Device Cleared for Pediatric ACL Surgery
Devices Orthopaedic FDA
 HSMN NewsFeed - 9 Jan 2023
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Jan 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2023
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 23 Dec 2022
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 15 Dec 2022
Providence Medical Technology announces FDA Clearance of the CAVUX(R) Facet Fixation System for the treatment of Cervical Pseudarthrosis
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 14 Dec 2022
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Dec 2022
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
Devices Neurosurgery FDA
 HSMN NewsFeed - 7 Dec 2022
Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Dec 2022
Deep Blue Medical Advances Announces FDA Clearance for Sublay Application in Hernia Surgery, Enabling Broader Use of T-Line Hernia Mesh
Devices Surgery FDA
 HSMN NewsFeed - 2 Dec 2022
SciNeuro Pharmaceuticals Announces the Appointment of Guojun Bu, Ph.D., as Chief Scientific Officer, and Provides Update on Pipeline of Novel CNS Therapeutics
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2022
Chemomab Announces Appointment of Mitchell L. Jones, MD, PhD as Vice President of Corporate Development & Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2022
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 23 Nov 2022
BioMarin Announces Advancements in FDA Review of ROCTAVIAN(TM) (Valoctocogene Roxaparvovec) for Adults with Severe Hemophilia A
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Nov 2022
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
Devices Dermatology FDA
 HSMN NewsFeed - 21 Nov 2022
Zimmer Biomet Expands Persona(R) Knee System Portfolio with FDA Clearance of Persona(R) OsseoTi(R) Keel Tibia for Cementless Knee Replacement
Devices Orthopaedic FDA
 HSMN NewsFeed - 15 Nov 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Nov 2022
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 8 Nov 2022
Sensorium Therapeutics Closes $30 Million Series A to Transform Mental Health Treatment with Nature-Inspired Psychoactive Medicines
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Nov 2022
US Biologic(R) to Present Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 31 Oct 2022
Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial of Iomab-B in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Oct 2022
Geistlich Pharma North America, Inc. Acquires Lynch Biologics, LLC, a Biologics and Tissue Engineering Company
Regenerative Medicine Surgery Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2022
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 Oct 2022
Medtronic Announces Intention to Separate its Combined Patient Monitoring and Respiratory Interventions Businesses
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2022
ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
Devices Oncology
 HSMN NewsFeed - 20 Oct 2022
DePuy Synthes Receives FDA Clearance for TELIGEN(TM) System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 17 Oct 2022
Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Oct 2022
Biosense Webster Launches HELIOSTAR(TM) in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 6 Oct 2022
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
Devices Dermatology FDA
 HSMN NewsFeed - 4 Oct 2022
Pacertool Establishes World-Class Scientific Advisory Board
Devices Cardiology Personnel
 HSMN NewsFeed - 3 Oct 2022
Alexion, AstraZeneca Rare Disease to Acquire LogicBio(R) Therapeutics to Accelerate Growth in Genomic Medicine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2022
B. Braun Acquires Clik-FIX(R) Catheter Securement Devices from Starboard Medical
Devices Acquisitions
 HSMN NewsFeed - 26 Sep 2022
BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay
Diagnostics Product Launch
 HSMN NewsFeed - 22 Sep 2022
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Sep 2022
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
Devices Oncology
 HSMN NewsFeed - 19 Sep 2022
AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI(R)) for the Treatment of Adults with Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 16 Sep 2022
Supira Medical Announces Successful First-In-Human Use Of Its Next Generation Percutaneous Ventricular Assist Device
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Sep 2022
Marengo Therapeutics Advances First-In-Class Selective T cell Activator, STAR0602, into Human Trials in Solid Tumors and Enters Cooperative Research and Development Agreement with the National Cancer Institute
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Sep 2022
Excision Medical Inc. Announces $2.5M Funding and Two Important Additions to its Scientific Advisory Board
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 15 Sep 2022
Alphyn Biologics Closes $3.3 Million Series A Financing to Advance Breakthrough Atopic Dermatitis Treatment
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 13 Sep 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
Devices Interventional Neurology Venture Capital
 HSMN NewsFeed - 13 Sep 2022
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
Devices Product Launch
 HSMN NewsFeed - 13 Sep 2022
Ventris Medical Receives 510(k) Clearance for Amplify(R) Standalone Bone Graft Putty and Bone Graft Extender
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 12 Sep 2022
Haemonetics Earns CE Mark for VASCADE(R) Vascular Closure Product Portfolio
Devices Interventional Regulatory
 HSMN NewsFeed - 8 Sep 2022
GenesisCare Purchases Two Additional ViewRay MRIdian MRI-guided Radiotherapy Systems for Guildford and Birmingham Projects, Doubling United Kingdom Footprint to Four Systems
Devices Oncology
 HSMN NewsFeed - 7 Sep 2022
Serpex Medical Announces Second FDA 510(k) Clearance of its Steerable Endobronchial Instrument Platform - The Compass Steerable Needle
Devices FDA
 HSMN NewsFeed - 7 Sep 2022
COUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2022
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
Devices Oncology Regulatory
 HSMN NewsFeed - 6 Sep 2022
First Randomized Controlled Study with RejuvenAir(R) for Chronic Bronchitis shows Clinically Significant Results
Devices Drug Delivery Interventional
 HSMN NewsFeed - 6 Sep 2022
Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX(TM) LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 31 Aug 2022
Medtronic announces partnership with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearable for continuous remote patient monitoring from in-hospital to home
Devices Monitoring Distribution
 HSMN NewsFeed - 30 Aug 2022
Medtronic completes acquisition of Affera
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 29 Aug 2022
Össur Acquires Naked Prosthetics
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2022
3T Biosciences Debuts with $40 Million Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 24 Aug 2022
Plexium Strengthens Leadership Team with Appointment of Daniel Sipes as Senior Vice President, Head of Technology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Aug 2022
Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2022
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology
 HSMN NewsFeed - 23 Aug 2022
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 18 Aug 2022
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2022
Boston Scientific Announces Acquisition of Obsidio, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2022
Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2022
Cardinal Health Announces Leadership Changes
Devices Biopharmaceuticals Distribution Personnel
 HSMN NewsFeed - 10 Aug 2022
GentiBio Announces Collaboration with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for Inflammatory Bowel Diseases
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 9 Aug 2022
ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Aug 2022
Eleven Therapeutics Announces $22 Million in Seed Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jul 2022
Checkpoint Surgical launches Checkpoint Edge(TM) Nerve Cutting Kit, extending the company's intraoperative nerve care portfolio
Devices Surgery Product Launch
 HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Jul 2022
Metabolon Appoints Tom Houseman as Vice President of Operations
Biopharmaceutical Personnel
 HSMN NewsFeed - 21 Jul 2022
Molecular Testing Labs Announces Selection of Eric Strafel as New CEO
Diagnostics Personnel
 HSMN NewsFeed - 21 Jul 2022
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Jul 2022
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
Devices Ophthalmology
 HSMN NewsFeed - 20 Jul 2022
Nuvalent Announces Leadership Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Jul 2022
Saitama Medical University International Medical Center Selects MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology
 HSMN NewsFeed - 18 Jul 2022
Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmology
Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 15 Jul 2022
Subtle Medical Announces Partnership Expansion With Incepto
Devices Radiology
 HSMN NewsFeed - 12 Jul 2022
B. Braun Launches Introcan Safety(R) 2 IV Catheter with One-time Blood Control Designed to Make IV Access Safer for Clinicians
Devices Product Launch
 HSMN NewsFeed - 11 Jul 2022
Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jul 2022
Biolase Announces Promotions of Key Team Members
Devices Dental Personnel
 HSMN NewsFeed - 5 Jul 2022
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy
Devices Neurology
 HSMN NewsFeed - 30 Jun 2022
Smith & Nephew announces first robotic-assisted surgery using its LEGION(TM) CONCELOC(TM) Cementless Total Knee System
Devices Orthopaedic
 HSMN NewsFeed - 30 Jun 2022
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
Diagnostics Product Launch
 HSMN NewsFeed - 29 Jun 2022
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2022
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2022
BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Jun 2022
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
ddR
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!